A recent analysis reveals a dramatic decrease in RSV-associated hospitalizations among infants aged 0-7 months during the 2024-25 season, thanks to the widespread use of maternal vaccination and nirsevimab. This significant reduction highlights the effectiveness of preventive measures and underscores the importance of early intervention.
Flu activity in the U.S. is declining, yet hospitalizations remain high. The CDC reports nearing 100 pediatric deaths this season. What does this mean for public health?
